Redmond Asset Management, LLC Transcode Therapeutics, Inc. Transaction History

Redmond Asset Management, LLC

  • $305 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.01 - $952.0 $161 - $152,320
-160 Reduced 0.18%
90,874 $100,000
Q1 2022

May 03, 2022
BUY
$2.03 - $3.01 $6,138 - $9,102
3,024 Added 3.44%
91,034 $262,000
Q4 2021

Feb 04, 2022
BUY
$2.42 - $3.41 $212,984 - $300,114
88,010 New
88,010 $224,000

Others Institutions Holding RNAZ

# of Institutions
1
Shares Held
6.5K
Call Options Held
0
Put Options Held
0
View Full List

About Transcode Therapeutics, Inc.

RNAZ Quotes by TradingView
  • Ticker RNAZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,977,200
  • Market Cap $45.7M
  • Description
  • TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...
More about RNAZ
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email